Spanish family study on hereditary breast and/or ovarian cancer: analysis of the BRCA1 gene.

No abstract is available for this paper.

• Publication year

  2001

• Venue

  International Journal of Cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0215(20010101)91:1<137::AID-IJC1020>3.0.CO;2-R
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• BRCA1 mutation analysis in 83 Spanish breast and breast/ovarian cancer families

  1999cited by this paper
• A highly accurate, low cost test forBRCA1 mutations

  1999cited by this paper
• Breast Cancer Genes and DNA Repair

  1999cited by this paper
• Screening for germ-line rearrangements and regulatory mutations in BRCA1 led to the identification of four new deletions.

  1999cited by this paper
• Prevalence of BRCA1 and BRCA2 gene mutations in patients with early-onset breast cancer.

  1999cited by this paper
• Denaturing gradient gel electrophoresis-based analysis of loss of heterozygosity distinguishes nonobvious, deleterious BRCA1 variants from nonpathogenic polymorphisms.

  1999cited by this paper
• Regulation of BRCA1 and BRCA2 expression in human breast cancer cells by DNA-damaging agents

  1998cited by this paper
• Low incidence of BRCA1 mutations among Italian families with breast and ovarian cancer

  1998cited by this paper
• BRCA1 as a potential human prostate tumor suppressor: modulation of proliferation, damage responses and expression of cell regulatory proteins

  1998cited by this paper
• Detection of BRCA1 gene mutations in families with breast cancer patients and their healthy relatives.

  1998cited by this paper
• Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium.

  1998cited by this paper
• BRCA1 sequence variations in 160 individuals referred to a breast/ovarian family cancer clinic. Institut Curie Breast Cancer Group.

  1997cited by this paper
• A high proportion of novel mutations in BRCA1 with strong founder effects among Dutch and Belgian hereditary breast and ovarian cancer families.

  1997cited by this paper
• Common BRCA1 variants and susceptibility to breast and ovarian cancer in the general population.

  1997cited by this paper
• Population genetics of BRCA1 and BRCA2.

  1997cited by this paper
• Genetic testing: The problems and the promise

  1997cited by this paper
• Mutations and alternative splicing of the BRCA1 gene in UK breast/ovarian cancer families

  1997cited by this paper
• Transcriptional activation by BRCA1

  1996cited by this paper
• A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1.

  1994cited by this paper
• Genetic linkage analysis in familial breast and ovarian cancer: results from 214 families. The Breast Cancer Linkage Consortium.

  1993cited by this paper

• Prevalencia mutacional de los genes BRCA1 y BRCA2 en pacientes con cáncer de mama y ovario atendidos en el Área de Salud de La Ribera (Comunidad Valenciana, España)

  2016cites this paper
• Changes in the expression of plasma proteins associated with thrombosis in BRCA1 mutation carriers

  2012cites this paper
• Genomic rearrangements of the BRCA1 gene in Chilean breast cancer families: an MLPA analysis

  2011cites this paper
• Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.

  2009cites this paper
• Mutaciones de BRCA1 y BRCA2 en familias estudiadas en el Programa de Consejo Genético en el Cáncer de la Comunidad Valenciana

  2008cites this paper
• LOS GENES BRCA1 y BRCA2. ESTUDIO MOLECULAR

  2006cites this paper
• The breast cancer low‐penetrance allele 1100delC in the CHEK2 gene is not present in Spanish familial breast cancer population

  2004cites this paper
• Cancer screening and genetic counseling

  2004cites this paper
• Analysis of BRCA1 and BRCA2 genes in Spanish breast/ovarian cancer patients: A high proportion of mutations unique to Spain and evidence of founder effects

  2003cites this paper
• Over-representation of two specific haplotypes among chromosomes harbouring BRCA1 mutations

  2003cites this paper
• No mutations in the XRCC2 gene in BRCA1/2‐negative high‐risk breast cancer families

  2003cites this paper
• A breast cancer family from Spain with germline mutations in both the BRCA1 and BRCA2 genes

  2002cites this paper
• Low frequency of recurrent BRCA1 and BRCA2 mutations in Spain

  2002cites this paper
• LOS SO FHETEROZYGOSIT YANALYSI SA TTH EBRC ALOC II NTUMOR SAMPLE SFRO MPATIENT SWIT HFAMILIA LBREAS TCANCER

  2002cites this paper